Opening book details…
About this Medicine article
Phase II study of the proteasome inhibitor bortezomib (PS-341, Velcade®) in chemotherapy-naïve patients with advanced stage non-small cell lung cancer (NSCLC) by Li, Tianhong; Ho, Liawaty; Piperdi, Bilal; Elrafei, Tarek; Camacho, Fernando J.; Rigas, James R.; Perez-Soler, Roman; Gucalp, Rasim is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Li, Tianhong; Ho, Liawaty; Piperdi, Bilal; Elrafei, Tarek; Camacho, Fernando J.; Rigas, James R.; Perez-Soler, Roman; Gucalp, Rasim
- Publisher
- Elsevier Science; Elsevier ; Elsevier BV (ISSN 0169-5002)
- Published
- 2010
- Field
- Medicine (Health Sciences)